Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer

Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin [Internet]. 2017;67:122–37. Available from: http://doi.wiley.com/10.3322/caac.21389. Grégoire, 2010, EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol [Internet]., 21, v184, 10.1093/annonc/mdq185 “National Comprehensive Cancer Network.” National Comprehensive Cancer Network Guidelines for Head and Neck Cancers (version 2.2020) [Internet]. 2020 [cited 2020 May 8]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Sun R, Tang X, Yang Y, Zhang C. (18)FDG-PET/CT for the detection of regional nodal metastasis in patients with head and neck cancer: a meta-analysis. Oral Oncol [Internet]. Elsevier Ltd; 2015;51:314–20. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1368837515000056. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol [Internet]. 2003 [cited 2014 Sep 29];21:555–63. Available from: http://www.jco.org/cgi/doi/10.1200/JCO.2003.04.171. Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder DB, et al. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database. Cancer [Internet]. 2015;121:1204–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25490875. Castelli J, Depeursinge A, Ndoh V, Prior JO, Ozsahin M, Devillers A, et al. A PET-based nomogram for oropharyngeal cancers. Eur J Cancer [Internet]. Elsevier Ltd; 2017;75:222–30. Available from: http://dx.doi.org/10.1016/j.ejca.2017.01.018. Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk J a, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol [Internet]. 2014 [cited 2014 Jun 8];110:172–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24183870. Jorgensen JB, Smith RB, Coughlin A, Spanos WC, Lohr MM, Sperry SM, et al. Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell Carcinoma. Otolaryngol Neck Surg [Internet]. 2019;160:261–6. Available from: http://journals.sagepub.com/doi/10.1177/0194599818794479. Adams S, Baum RP, Stuckensen T, Bitter K, Hör G. Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med Mol Imaging [Internet]. 1998;25:1255–60. Available from: http://link.springer.com/10.1007/s002590050293. Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, et al. Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Histopathologic Correlation in the Initial Staging of Head and Neck Cancer. Ann Surg [Internet]. 2002;236:208–17. Available from: http://journals.lww.com/00000658-200208000-00009. Ng S-H, Yen T-C, Chang JT-C, Chan S-C, Ko S-F, Wang H-M, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol [Internet]. 2006;24:4371–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16983105. Yoon DY, Hwang HS, Chang SK, Rho Y-S, Ahn HY, Kim JH, et al. CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol [Internet]. 2009;19:634–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18843493. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JPA. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: A meta-analysis. JNCI J Natl Cancer Inst [Internet]. 2008;100:712–20. Available from: https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/djn125. Xu G-Z, Zhu X-D, Li M-Y. Accuracy of whole-body PET and PET-CT in initial M staging of head and neck cancer: A meta-analysis. Head Neck [Internet]. 2011;33:87–94. Available from: http://doi.wiley.com/10.1002/hed.21400. Kim MRR, Roh J-LL, Kim JSS, Lee JHH, Cho K-JJ, Choi S-HH, et al. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx. Eur J Surg Oncol [Internet]. 2007;33:633–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0748798307000807. Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck [Internet]. 2010;32:319–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19626642. Schwartz DL, Rajendran J, Yueh B, Coltrera M, Anzai Y, Krohn K, et al. Staging of Head and Neck Squamous Cell Cancer With Extended-Field FDG-PET. Arch Otolaryngol Neck Surg [Internet]. 2003;129:1173. Available from: http://archotol.jamanetwork.com/article.aspx?doi=10.1001/archotol.129.11.1173. Britt CJ, Maas AM, Kennedy TA, Hartig GK. Incidental Findings on FDG PET/CT in Head and Neck Cancer. Otolaryngol Head Neck Surg [Internet]. 2018;158:484–8. Available from: http://journals.sagepub.com/doi/10.1177/0194599817742579. Cacicedo J, Navarro A, Del Hoyo O, Gomez-Iturriaga A, Alongi F, Medina JA, et al. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist. Br J Radiol [Internet]. 2016;89:20160217. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27416996. Scott, 2008, PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study, J Nucl Med., 49, 1593, 10.2967/jnumed.108.053660 Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, et al. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol [Internet]. 2010;28:1190–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20124179. A. Connell C, Corry J, Milner AD, Hogg A, Hicks RJ, Rischin D, et al. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck [Internet]. 2007;29:986–95. Available from: http://doi.wiley.com/10.1002/hed.20629. Cacicedo J, Fernandez I, del Hoyo O, Dolado A, Gómez-Suarez J, Hortelano E, et al. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis. Eur J Nucl Med Mol Imaging [Internet]. 2015; Available from: http://link.springer.com/10.1007/s00259-015-3071-0. Mazzola R, Alongi P, Ricchetti F, Fiorentino A, Fersino S, Giaj-Levra N, et al. 18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the stage migration and nodal radiation treatment volumes. Radiol Med [Internet]. Springer Milan; 2017;122:952–9. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/718/CN-01251718/frame.html. Hollenbeak CS, Lowe VJ, Stack BC. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck. Cancer [Internet]. 2001;92:2341–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11745289. Kurien, 2011, Cost-effectiveness of positron emission tomography/computed tomography in the management of advanced head and neck cancer, J Otolaryngol - Head Neck Surg., 40, 468 Annunziata S, Caldarella C, Treglia G. Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review. World J Radiol [Internet]. 2014;6:48–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24765240. Mehanna H, Wong W-L, McConkey CC, Rahman JK, Robinson M, Hartley AGJ, et al. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. N Engl J Med [Internet]. 2016;374:1444–54. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1514493.